Followers | 50 |
Posts | 12552 |
Boards Moderated | 0 |
Alias Born | 06/15/2014 |

Saturday, December 21, 2024 5:36:45 PM
I will say that there seems to be one point that he may have and that I find confusing myself. If anyone can better explain this one top line bullet point in the press release I would appreciate it:
Operator
05/09/2024 at 06:17 PM
This is a common misconception that this strip is common area, but it is actually a part of your lot and needs to be maintained the same as your lawn. No worries though, we are only recently sending out letters/citations about landscape maintenance so you do not need to worry about being fined in the meantime. For reference, it takes close to two months for us to issue fines following the initial citation, so you have plenty of time to make arrangements to accommodate this.
"14.5% relative improvement in DFS observed at 54 months for the CAN-2409 treatment arm compared to the placebo control arm"
I am not sure exactly what they are saying. I know AF also questions why specifically the 54 months. TIA
Recent CADL News
- Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients • GlobeNewswire Inc. • 04/01/2025 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2025 01:57:07 AM
- Candel Therapeutics Reports Both Prolonged Median Overall Survival and Long Tail of Survival in Phase 2a Clinical Trial of CAN-2409 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment • GlobeNewswire Inc. • 03/26/2025 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 08:36:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2025 08:35:42 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/20/2025 08:35:16 PM
- Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409 • GlobeNewswire Inc. • 03/20/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 08:12:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/19/2025 08:06:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2025 08:29:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/18/2025 08:29:39 PM
- Candel Therapeutics Appoints Renowned Pancreatic Cancer Expert, Elizabeth M. Jaffee, M.D., to Research Advisory Board • GlobeNewswire Inc. • 03/18/2025 12:00:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2025 08:29:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/17/2025 08:29:31 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/13/2025 08:45:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2025 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2025 08:15:08 PM
- Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/13/2025 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2025 01:15:09 PM
- Candel Therapeutics Announces Positive Final Survival Data from Randomized Controlled Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer • GlobeNewswire Inc. • 02/25/2025 01:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 09:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 09:30:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2025 09:30:03 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit • AVAI • Apr 16, 2025 8:00 AM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM